Shares of Cybin Inc. (OTCMKTS:CLXPF – Get Free Report) reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $8.56 and last traded at $8.56, with a volume of 569287 shares trading hands. The stock had previously closed at $7.75.
Cybin Price Performance
The stock’s fifty day simple moving average is $0.43 and its 200-day simple moving average is $0.38. The company has a market capitalization of $1.36 billion and a P/E ratio of -38.25.
About Cybin
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Featured Stories
- Five stocks we like better than Cybin
- 3 Stocks to Consider Buying in October
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- What Are Dividend Contenders? Investing in Dividend Contenders
- MarketBeat Week in Review – 9/16 – 9/20
- How to Invest in the FAANG Stocks
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
